Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets

Molecular Immunology

Volumn 45, Issue 9, 2008, Pages 2607-2620

  Rolf, Julia ^a   Berntman, Emma ^b   Stenström, Martin ^b   Smith, Emma M K ^c   Månsson, Robert ^c   Stenstad, Hanna ^a,b   Yamagata, Tetsuya ^d   Agace, William ^b   Sigvardsson, Mikael ^c,e   Cardell, Susanna L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e LINKÖPING UNIVERSITY   (Sweden)

Author keywords

CD1d; Gene expression; NKT cells; Transcription factors

Indexed keywords

CD1D ANTIGEN; CHEMOKINE RECEPTOR; INTEGRIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL TYPE; EFFECTOR CELL; FEMALE; GENE; GENE EXPRESSION PROFILING; IMMUNITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOKINE; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 40849101435     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.12.022     Document Type: Article

References (63)

1. Akbari O., Faul J.L., Hoyte E.G., Berry G.J., Wahlstrom J., Kronenberg M., DeKruyff R.H., and Umetsu D.T. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354 (2006) 1117-1129
2. Baron J.L., Gardiner L., Nishimura S., Shinkai K., Locksley R., and Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16 (2002) 583-594
3. Beaudoin L., Laloux V., Novak J., Lucas B., and Lehuen A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 17 (2002) 725-736
4. Behar S.M., Podrebarac T.A., Roy C.J., Wang C.R., and Brenner M.B. Diverse TCRs recognize murine CD1. J. Immunol. 162 (1999) 161-167
5. Bendelac A., Bonneville M., and Kearney J.F. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1 (2001) 177-186
6. Bendelac A., Hunziker R.D., and Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184 (1996) 1285-1293
7. Bendelac A., Lantz O., Quimby M.E., Yewdell J.W., Bennink J.R., and Brutkiewicz R.R. CD1 recognition by mouse NK1+ T lymphocytes. Science 268 (1995) 863-865
8. Bendelac A., Rivera M.N., Park S.H., and Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15 (1997) 535-562
9. Bendelac A., Savage P.B., and Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
10. Campbell D.J., Kim C.H., and Butcher E.C. Chemokines in the systemic organization of immunity. Immunol. Rev. 195 (2003) 58-71
11. Cardell S., Tangri S., Chan S., Kronenberg M., Benoist C., and Mathis D. CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182 (1995) 993-1004
12. Cardell S.L. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 143 (2006) 194-202
13. Chi H., Lu B., Takekawa M., Davis R.J., and Flavell R.A. GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells. EMBO J. 23 (2004) 1576-1586
14. Denning T.L., Granger S.W., Mucida D., Graddy R., Leclercq G., Zhang W., Honey K., Rasmussen J.P., Cheroutre H., Rudensky A.Y., and Kronenberg M. Mouse TCRalphabeta+CD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J. Immunol. 178 (2007) 4230-4239
15. Duarte N., Stenstrom M., Campino S., Bergman M.-L., Lundholm M., Holmberg D., and Cardell S. Prevention of diabetes in non obese diabetic (NOD) mice mediated by non-classical NKT cells. J. Immunol. 173 (2004) 3112-3118
16. Exley M.A., Bigley N.J., Cheng O., Shaulov A., Tahir S.M., Carter Q.L., Garcia J., Wang C., Patten K., Stills H.F., Alt F.W., Snapper S.B., and Balk S.P. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 110 (2003) 519-526
17. Fahrer A.M., Konigshofer Y., Kerr E.M., Ghandour G., Mack D.H., Davis M.M., and Chien Y.H. Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10261-10266
18. Fan Z., Yu P., Wang Y., Wang Y., Fu M.L., Liu W., Sun Y., and Fu Y.X. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107 (2006) 1342-1351
19. Fourie A.M., Coles F., Moreno V., and Karlsson L. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278 (2003) 30469-30477
20. Fuss I.J., Heller F., Boirivant M., Leon F., Yoshida M., Fichtner-Feigl S., Yang Z., Exley M., Kitani A., Blumberg R.S., Mannon P., and Strober W. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113 (2004) 1490-1497
21. Geissmann F., Cameron T.O., Sidobre S., Manlongat N., Kronenberg M., Briskin M.J., Dustin M.L., and Littman D.R. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3 (2005) e113
22. Godfrey D.I., and Berzins S.P. Control points in NKT-cell development. Nat. Rev. Immunol. 7 (2007) 505-518
23. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., and Van Kaer L. NKT cells: what's in a name?. Nat. Rev. Immunol. 4 (2004) 231-237
24. Gu X., Laouar A., Wan J., Daheshia M., Lieberman J., Yokoyama W.M., Katz H.R., and Manjunath N. The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J. Immunol. 170 (2003) 4095-4101
25. Gumperz J.E., Miyake S., Yamamura T., and Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195 (2002) 625-636
26. Gumperz J.E., Roy C., Makowska A., Lum D., Sugita M., Podrebarac T., Koezuka Y., Porcelli S.A., Cardell S., Brenner M.B., and Behar S.M. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12 (2000) 211-221
27. Hammond K.J., and Kronenberg M. Natural killer T cells: natural or unnatural regulators of autoimmunity?. Curr. Opin. Immunol. 15 (2003) 683-689
28. Heller F., Fuss I.J., Nieuwenhuis E.E., Blumberg R.S., and Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
29. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R.C., and Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199 (2004) 947-957 Epub 2004 Mar 29
30. Johnston B., Kim C.H., Soler D., Emoto M., and Butcher E.C. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J. Immunol. 171 (2003) 2960-2969
31. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
32. Laloux V., Beaudoin L., Jeske D., Carnaud C., and Lehuen A. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166 (2001) 3749-3756
33. Lee P.T., Benlagha K., Teyton L., and Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195 (2002) 637-641
34. Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A., Bach J.F., and Monteiro R.C. Overexpression of natural killer T cells protects V alpha 14-J alpha 281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188 (1998) 1831-1839
35. Leite-De-Moraes M.C., Hameg A., Arnould A., Machavoine F., Koezuka Y., Schneider E., Herbelin A., and Dy M. A distinct IL-18-induced pathway to fully activate NKT lymphocytes independently from TCR engagement. J. Immunol. 163 (1999) 5871-5876
36. Leite-De-Moraes M.C., Hameg A., Pacilio M., Koezuka Y., Taniguchi M., Van Kaer L., Schneider E., Dy M., and Herbelin A. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166 (2001) 945-951
37. Lin H., Nieda M., Hutton J.F., Rozenkov V., and Nicol A.J. Comparative gene expression analysis of NKT cell subpopulations. J. Leukoc. Biol. 80 (2006) 164-173
38. Lo J.C., Wang Y., Tumanov A.V., Bamji M., Yao Z., Reardon C.A., Getz G.S., and Fu Y.X. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 316 (2007) 285-288
39. Mack D.L., Leibowitz D.S., Cooper S., Ramsey H., Broxmeyer H.E., and Hromas R. Down-regulation of the myeloid homeobox protein Hex is essential for normal T-cell development. Immunology 107 (2002) 444-451
40. Makowska A., Kawano T., Taniguchi M., and Cardell S. Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire. Scand. J. Immunol. 52 (2000) 71-79
41. Matsuda J.L., and Gapin L. Developmental program of mouse Valpha14i NKT cells. Curr. Opin. Immunol. 17 (2005) 122-130
42. Matsuda J.L., Zhang Q., Ndonye R., Richardson S.K., Howell A.R., and Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107 (2006) 2797-2805
43. Mempel M., Ronet C., Suarez F., Gilleron M., Puzo G., Van Kaer L., Lehuen A., Kourilsky P., and Gachelin G. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168 (2002) 365-371
44. Niemeyer M., Darmoise A., Mollenkopf H.J., Hahnke K., Hurwitz R., Besra G.S., Schaible U.E., and Kaufmann S.H. Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses. Immunology 123 (2007) 45-56
45. Park S.H., Weiss A., Benlagha K., Kyin T., Teyton L., and Bendelac A. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J. Exp. Med. 193 (2001) 893-904
46. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., Banica M., DiCioccio C.B., Gross D.A., Mao C.A., Shen H., Cereb N., Yang S.Y., Lindsten T., Rossant J., Hunter C.A., and Reiner S.L. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302 (2003) 1041-1043
47. Pennington D.J., Silva-Santos B., Shires J., Theodoridis E., Pollitt C., Wise E.L., Tigelaar R.E., Owen M.J., and Hayday A.C. The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells. Nat. Immunol. 4 (2003) 991-998
48. Porcelli S.A., and Modlin R.L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17 (1999) 297-329
49. Roark J.H., Park S.H., Jayawardena J., Kavita U., Shannon M., and Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160 (1998) 3121-3127
50. Skold M., Faizunnessa N.N., Wang C.R., and Cardell S. CD1d-specific NK1.1+ T cells with a transgenic variant TCR. J. Immunol. 165 (2000) 168-174
51. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., and Godfrey D.I. NKT cells-conductors of tumor immunity?. Curr. Opin. Immunol. 14 (2002) 165-171
52. Stenstad H., Ericsson A., Johansson-Lindbom B., Svensson M., Marsal J., Mack M., Picarella D., Soler D., Marquez G., Briskin M., and Agace W.W. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 107 (2006) 3447-3454
53. Stenstrom M., Skold M., Ericsson A., Beaudoin L., Sidobre S., Kronenberg M., Lehuen A., and Cardell S. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type. Eur. J. Immunol. 34 (2004) 56-65
54. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.E., Gapin L., Kronenberg M., and Locksley R.M. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198 (2003) 1069-1076
55. Svensson M., Marsal J., Ericsson A., Carramolino L., Broden T., Marquez G., and Agace W.W. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J. Clin. Invest. 110 (2002) 1113-1121
56. Swann J.B., Coquet J.M., Smyth M.J., and Godfrey D.I. CD1-restricted T cells and tumor immunity. Curr. Top. Microbiol. Immunol. 314 (2007) 293-323
57. Terabe M., Swann J., Ambrosino E., Sinha P., Takaku S., Hayakawa Y., Godfrey D.I., Ostrand-Rosenberg S., Smyth M.J., and Berzofsky J.A. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202 (2005) 1627-1633
58. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., and Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20 (2004) 477-494
59. Tupin E., Kinjo Y., and Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5 (2007) 405-417
60. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
61. Yamagata T., Mathis D., and Benoist C. Self-reactivity in thymic double-positive cells commits cells to a CD8 alpha alpha lineage with characteristics of innate immune cells. Nat. Immunol. 5 (2004) 597-605
62. Yamaguchi A., Koda T., Abe H., Sato M., Li J., Sakai T., Togashi Y., Shinohara Y., Ikeda H., and Nishimura T. Development of a functional cDNA array for evaluation of the Th1/Th2 balance. Immunol. Lett. 101 (2005) 95-103
63. Zeng D., Dick M., Cheng L., Amano M., Dejbakhsh-Jones S., Huie P., Sibley R., and Strober S. Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J. Exp. Med. 187 (1998) 525-536